Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Osteochondroma 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Lung Neoplasms 1Hematologic Neoplasms 1Giant Cell Tumors 1Fibrosis 1Endometrial Hyperplasia 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 80Surgical Procedures, Operative 53Observation 44Drug Therapy 44Colonoscopy 41Bevacizumab 41Biopsy 35Hepatectomy 33Capecitabine 27Neoadjuvant Therapy 26Immune Checkpoint Inhibitors 26regorafenib 25Interviews as Topic 25Radiotherapy 24Oxaliplatin 24Sorafenib 22Magnetic Resonance Spectroscopy 22lenvatinib 21Endoscopic Mucosal Resection 21Specimen Handling 18Immunohistochemistry 18Endoscopy 18Pancreaticoduodenectomy 17Liquid Biopsy 17Gastrectomy 17Endoscopic Ultrasound-Guided Fine Needle Aspiration 17Tomography, X-Ray Computed 16Gastroscopy 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Sampling Studies × Gastrointestinal × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡